Apimeds Pharmaceuticals 8-K Delisting Notice, Matawan, NJ, 22nd Apr
Summary
Apimeds Pharmaceuticals, a pharmaceutical company based in Matawan, NJ, filed an 8-K current report with the SEC on April 22, providing formal notice of delisting. The filing was submitted under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard), which triggers the exchange's delisting procedures. Public shareholders and investors should monitor the company's continued disclosure obligations during the delisting process.
About this source
GovPing monitors EDGAR: Delisting Notices (8-K 3.01) for new securities & markets regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 30 changes logged to date.
What changed
Apimeds Pharmaceuticals filed an 8-K current report with the SEC providing notice of delisting under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard). The filing was made on April 22, 2026, from the company's headquarters in Matawan, NJ.
Public shareholders and investors tracking Apimeds should monitor for subsequent 8-K filings as the delisting process unfolds, including any notification from the applicable stock exchange regarding suspension of trading and final delisting dates.
Named provisions
Mentioned entities
Related changes
Get daily alerts for EDGAR: Delisting Notices (8-K 3.01)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from SEC.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EDGAR: Delisting Notices (8-K 3.01) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.